AYESHA AHMED: Open Payments
NPI 1760017339 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $234 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Tonix Medicines, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TAVNEOS, SAPHNELO, ZEMBRACE SYMTOUCH, BENLYSTA, SKYRIZI, HYQVIA.
Industry payments across MO — which companies pay providers there.
